Combination measles, mumps, rubella and varicella vaccine.

Stuart E. Starr , Stanley A. Plotkin , Linda Baker , Elizabeth Books
Pediatrics 78 ( 4) 742 -747

44
1986
Cutting Edge: CTLA-4 Ligation Delivers a Unique Signal to Resting Human CD4 T Cells That Inhibits Interleukin-2 Secretion but Allows Bcl-XL Induction

Carl H. June , Tara Francomano , Bruce L. Levine , James L. Riley
Journal of Immunology 160 ( 1) 12 -15

139
1998
Icos critically regulates the expansion and function of inflammatory human th17 cells

Chrystal Paulos , Carl H. June , James L. Riley , Bruce L. Levine

31
2011
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

Michael Baseler , R. Michael Blaese , Susan F. Leitman , Michael A. Polis
Blood 96 ( 2) 467 -474

186
2000
Compositions for Treatment of Cancer

Carl H. June , Michael D. Kalos , Michael C. Milone , David L. Porter

147
2014
Phorbol Esters Induce Differentiation of Human CD34+ Hemopoietic Progenitors to Dendritic Cells: Evidence for Protein Kinase C-Mediated Signaling

David M. Harlan , Carl H. June , Bruce L. Levine , Kelvin P. Lee
Journal of Immunology 160 ( 8) 3689 -3697

63
1998
Methods for Treatment of Cancer

Carl H. June , Michael D. Kalos , Michael C. Milone , David L. Porter

64
2014
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.

George Coukos , Carl H. June , Larry R. Kaiser , Alanna J. Toll
Clinical Cancer Research 9 ( 4) 1517 -1527

81
2003
Novel gene and cellular therapy approaches for treating HIV.

Vijay G. Bhoj , Bruce L. Levine , Suzanne R. Thibodeaux
Discovery Medicine 21 ( 116) 283 -292

2
2016
Cell intrinsic PD-1 checkpoint blockade releases the brake on human chimeric antigen receptor (CAR) T cells for solid tumors

J. Joseph Melenhorst , Joseph A. Fraietta , Bruce L. Levine
Translational cancer research 5 ( 7)

2016
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells

Carl H. June , Michael C. Milone , Saba Ghassemi , Daniel J. Powell

26
2016
Compositions and Methods for Treatment of Cancer

Carl H. June , Michael D. Kalos , Michael C. Milone , David L. Porter

5
2016
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.

Carl H. June , E. John Wherry , Irina Kulikovskaya , Simon F. Lacey
Nature Medicine 27 ( 3) 561 -561

2021
Advances in automated cell washing and concentration.

Bruce L. Levine , Nathan Smith , Rebecca Lim , Dominic M. Wall
Cytotherapy

2021
Abstract IA10: CARs for leukemia and beyond?

Carl H. June , David Porter , Stephan Grupp , Bruce L. Levine
Clinical Cancer Research 21

2015
Adoptive immunotherapy: good habits instilled at youth have long-term benefits

Chrystal M. Paulos , Megan M. Suhoski , Gabriela Plesa , Tianying Jiang
Immunologic Research 42 ( 1) 182 -196

44
2008
Global Manufacturing of CAR T Cell Therapy

Bruce L. Levine , James Miskin , Keith Wonnacott , Christopher Keir
Molecular therapy. Methods & clinical development 4 92 -101

559
2017